Sees Karen L, Di Marino Michael E, Ruediger Nicole K, Sweeney Christine T, Shiffman Saul
Pinney Associates, Bethesda, MD 20814, USA.
J Pain Palliat Care Pharmacother. 2005;19(2):13-23.
The non-medical use of OxyContin (controlled release oxycodone HCl) Tablets has been widely cited in media reports often leaving the impression that OxyContin was a source of primary or new onset drug abuse. However, no published research to date has examined the drug use history of those reporting non-medical use of OxyContin. This study examined rates of non-medical OxyContin use in the United States and the demographic and drug use profiles of those reporting such use, based on data from the 1999, 2000, and 2001 Substance Abuse and Mental Health Services Administration National Household Survey on Drug Abuse. Reported lifetime non-medical OxyContin use in the United States increased from 0.1% to 0.2% to 0.4% in 1999, 2000, and 2001 suggesting new incidence of 0.1%-0.2% per year. Compared to those reporting non-medical use of prescription analgesics other than OxyContin, non-medical OxyContin users were more likely to show a pattern of more serious drug abuse: they used multiple drugs, used needles for drug injection, and had higher rates of abuse and dependence. Approximately 83% of non-medical OxyContin users reported having used illicit drugs or other prescription medications non-medically prior to their first non-medical use of prescription analgesics. Even compared to those who reported non-medical use of other prescription analgesics, non-medical OxyContin users already had a more significant pattern of drug abuse before they began using prescription analgesics for non-medical purposes, suggesting that non-medical use of OxyContin is rarely the initiating factor leading to the abuse of other drugs.
媒体报道中广泛提及了奥施康定(盐酸羟考酮控释片)的非医疗用途,这常常给人留下一种印象,即奥施康定是原发性或新发药物滥用的一个源头。然而,迄今为止,尚无已发表的研究对那些报告奥施康定非医疗用途者的用药史进行过调查。本研究基于1999年、2000年和2001年药物滥用和精神健康服务管理局全国药物滥用家庭调查的数据,对美国奥施康定非医疗用途的发生率以及报告有此类用途者的人口统计学和用药情况进行了调查。在美国,报告的奥施康定终生非医疗用途在1999年、2000年和2001年分别从0.1%增至0.2%,再增至0.4%,表明每年有0.1% - 0.2%的新发病率。与那些报告除奥施康定之外的其他处方镇痛药非医疗用途者相比,奥施康定非医疗用途使用者更有可能呈现出更严重的药物滥用模式:他们使用多种药物、使用针头注射药物,且滥用和依赖率更高。约83%的奥施康定非医疗用途使用者报告在首次非医疗使用处方镇痛药之前就曾非医疗使用非法药物或其他处方药。即便与那些报告其他处方镇痛药非医疗用途者相比,奥施康定非医疗用途使用者在开始将处方镇痛药用于非医疗目的之前就已经有更显著的药物滥用模式,这表明奥施康定的非医疗用途很少是导致滥用其他药物的起始因素。